748 related articles for article (PubMed ID: 18515322)
1. Differentiation block of oligodendroglial progenitor cells as a cause for remyelination failure in chronic multiple sclerosis.
Kuhlmann T; Miron V; Cui Q; Wegner C; Antel J; Brück W
Brain; 2008 Jul; 131(Pt 7):1749-58. PubMed ID: 18515322
[TBL] [Abstract][Full Text] [Related]
2. Gain of Olig2 function in oligodendrocyte progenitors promotes remyelination.
Wegener A; Deboux C; Bachelin C; Frah M; Kerninon C; Seilhean D; Weider M; Wegner M; Nait-Oumesmar B
Brain; 2015 Jan; 138(Pt 1):120-35. PubMed ID: 25564492
[TBL] [Abstract][Full Text] [Related]
3. Oligodendroglial lineage cells express nuclear p57kip2 in multiple sclerosis lesions.
Pfeifenbring S; Metz I; Kremer D; Küry P; Hartung HP; Brück W
Glia; 2013 Aug; 61(8):1250-60. PubMed ID: 23828667
[TBL] [Abstract][Full Text] [Related]
4. Oligodendrocyte progenitor cell susceptibility to injury in multiple sclerosis.
Cui QL; Kuhlmann T; Miron VE; Leong SY; Fang J; Gris P; Kennedy TE; Almazan G; Antel J
Am J Pathol; 2013 Aug; 183(2):516-25. PubMed ID: 23746653
[TBL] [Abstract][Full Text] [Related]
5. SOX17 is expressed in regenerating oligodendrocytes in experimental models of demyelination and in multiple sclerosis.
Moll NM; Hong E; Fauveau M; Naruse M; Kerninon C; Tepavcevic V; Klopstein A; Seilhean D; Chew LJ; Gallo V; Nait Oumesmar B
Glia; 2013 Oct; 61(10):1659-72. PubMed ID: 23918253
[TBL] [Abstract][Full Text] [Related]
6. Endogenous Nkx2.2+/Olig2+ oligodendrocyte precursor cells fail to remyelinate the demyelinated adult rat spinal cord in the absence of astrocytes.
Talbott JF; Loy DN; Liu Y; Qiu MS; Bunge MB; Rao MS; Whittemore SR
Exp Neurol; 2005 Mar; 192(1):11-24. PubMed ID: 15698615
[TBL] [Abstract][Full Text] [Related]
7. Oligodendroglia in cortical multiple sclerosis lesions decrease with disease progression, but regenerate after repeated experimental demyelination.
Rodriguez EG; Wegner C; Kreutzfeldt M; Neid K; Thal DR; Jürgens T; Brück W; Stadelmann C; Merkler D
Acta Neuropathol; 2014 Aug; 128(2):231-46. PubMed ID: 24563023
[TBL] [Abstract][Full Text] [Related]
8. Olig2 overexpression induces the in vitro differentiation of neural stem cells into mature oligodendrocytes.
Copray S; Balasubramaniyan V; Levenga J; de Bruijn J; Liem R; Boddeke E
Stem Cells; 2006 Apr; 24(4):1001-10. PubMed ID: 16253982
[TBL] [Abstract][Full Text] [Related]
9. Statin therapy inhibits remyelination in the central nervous system.
Miron VE; Zehntner SP; Kuhlmann T; Ludwin SK; Owens T; Kennedy TE; Bedell BJ; Antel JP
Am J Pathol; 2009 May; 174(5):1880-90. PubMed ID: 19349355
[TBL] [Abstract][Full Text] [Related]
10. Ceramide galactosyltransferase expression is regulated positively by Nkx2.2 and negatively by OLIG2.
Okahara K; Kizuka Y; Kitazume S; Ota F; Nakajima K; Hirabayashi Y; Maekawa M; Yoshikawa T; Taniguchi N
Glycobiology; 2014 Oct; 24(10):926-34. PubMed ID: 24821492
[TBL] [Abstract][Full Text] [Related]
11. Myelin transcription factor 1 (Myt1) expression in demyelinated lesions of rodent and human CNS.
Vana AC; Lucchinetti CF; Le TQ; Armstrong RC
Glia; 2007 May; 55(7):687-97. PubMed ID: 17330875
[TBL] [Abstract][Full Text] [Related]
12. Olig2-expressing progenitor cells preferentially differentiate into oligodendrocytes in cuprizone-induced demyelinated lesions.
Islam MS; Tatsumi K; Okuda H; Shiosaka S; Wanaka A
Neurochem Int; 2009; 54(3-4):192-8. PubMed ID: 19070638
[TBL] [Abstract][Full Text] [Related]
13. Activation of the subventricular zone in multiple sclerosis: evidence for early glial progenitors.
Nait-Oumesmar B; Picard-Riera N; Kerninon C; Decker L; Seilhean D; Höglinger GU; Hirsch EC; Reynolds R; Baron-Van Evercooren A
Proc Natl Acad Sci U S A; 2007 Mar; 104(11):4694-9. PubMed ID: 17360586
[TBL] [Abstract][Full Text] [Related]
14. Activation of FXR pathway does not alter glial cell function.
Albrecht S; Fleck AK; Kirchberg I; Hucke S; Liebmann M; Klotz L; Kuhlmann T
J Neuroinflammation; 2017 Mar; 14(1):66. PubMed ID: 28351411
[TBL] [Abstract][Full Text] [Related]
15. Myelin regulatory factor drives remyelination in multiple sclerosis.
Duncan GJ; Plemel JR; Assinck P; Manesh SB; Muir FGW; Hirata R; Berson M; Liu J; Wegner M; Emery B; Moore GRW; Tetzlaff W
Acta Neuropathol; 2017 Sep; 134(3):403-422. PubMed ID: 28631093
[TBL] [Abstract][Full Text] [Related]
16. Directing human neural stem/precursor cells into oligodendrocytes by overexpression of Olig2 transcription factor.
Maire CL; Buchet D; Kerninon C; Deboux C; Baron-Van Evercooren A; Nait-Oumesmar B
J Neurosci Res; 2009 Nov; 87(15):3438-46. PubMed ID: 19739249
[TBL] [Abstract][Full Text] [Related]
17. Cortical Remyelination Is Heterogeneous in Multiple Sclerosis.
Strijbis EMM; Kooi EJ; van der Valk P; Geurts JJG
J Neuropathol Exp Neurol; 2017 May; 76(5):390-401. PubMed ID: 28521040
[TBL] [Abstract][Full Text] [Related]
18. Co-localization of Nkx6.2 and Nkx2.2 homeodomain proteins in differentiated myelinating oligodendrocytes.
Cai J; Zhu Q; Zheng K; Li H; Qi Y; Cao Q; Qiu M
Glia; 2010 Mar; 58(4):458-68. PubMed ID: 19780200
[TBL] [Abstract][Full Text] [Related]
19. Oligodendrocyte survival, loss and birth in lesions of chronic-stage multiple sclerosis.
Wolswijk G
Brain; 2000 Jan; 123 ( Pt 1)():105-15. PubMed ID: 10611125
[TBL] [Abstract][Full Text] [Related]
20. Oligodendrocyte progenitor cell recruitment and remyelination in multiple sclerosis: the more, the merrier?
Tepavčević V; Lubetzki C
Brain; 2022 Dec; 145(12):4178-4192. PubMed ID: 36093726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
